Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
4.050
-0.100 (-2.41%)
At close: Dec 20, 2024, 4:00 PM
4.200
+0.150 (3.70%)
After-hours: Dec 20, 2024, 6:32 PM EST
Trevi Therapeutics Employees
Trevi Therapeutics had 25 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
25
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,772,680
Market Cap
311.31M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Viemed Healthcare | 996 |
Revance Therapeutics | 597 |
AirSculpt Technologies | 381 |
Tango Therapeutics | 140 |
Acelyrin | 135 |
Jasper Therapeutics | 45 |
enGene Holdings | 33 |
Immutep | 31 |
TRVI News
- 5 days ago - Trevi Therapeutics Announces Pricing of $50 Million Underwritten Offering - PRNewsWire
- 9 days ago - Why Is Cough-Focused Trevi Therapeutics Stock Skyrocketing On Thursday? - Benzinga
- 9 days ago - Trevi Therapeutics Announces Positive Outcome from Sample Size Re-estimation Resulting in No Change to the Current Sample Size for the Phase 2b CORAL Trial in Idiopathic Pulmonary Fibrosis Patients with Chronic Cough - PRNewsWire
- 18 days ago - Trevi Therapeutics Announces Positive Topline Results from Human Abuse Potential Study of Oral Nalbuphine - PRNewsWire
- 4 weeks ago - Trevi Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference - PRNewsWire
- 6 weeks ago - Trevi Therapeutics, Inc. (TRVI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Trevi Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates - PRNewsWire
- 7 weeks ago - Trevi Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on November 6, 2024 - PRNewsWire